[go: up one dir, main page]

WO2008130009A1 - 緑内障進行リスクの判定方法 - Google Patents

緑内障進行リスクの判定方法 Download PDF

Info

Publication number
WO2008130009A1
WO2008130009A1 PCT/JP2008/057533 JP2008057533W WO2008130009A1 WO 2008130009 A1 WO2008130009 A1 WO 2008130009A1 JP 2008057533 W JP2008057533 W JP 2008057533W WO 2008130009 A1 WO2008130009 A1 WO 2008130009A1
Authority
WO
WIPO (PCT)
Prior art keywords
glaucoma
allele
risk
genotype
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057533
Other languages
English (en)
French (fr)
Inventor
Shigeru Kinoshita
Kei Tashiro
Masakazu Nakano
Tomohito Yagi
Kazuhiko Mori
Yoko Ikeda
Takazumi Taniguchi
Masaaki Kageyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12/596,462 priority Critical patent/US8431345B2/en
Priority to MX2009011080A priority patent/MX2009011080A/es
Priority to CA002683836A priority patent/CA2683836A1/en
Priority to JP2009510857A priority patent/JP5624763B2/ja
Priority to BRPI0810425-5A2A priority patent/BRPI0810425A2/pt
Priority to EP08740595A priority patent/EP2161334A4/en
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to CN200880020582A priority patent/CN101679971A/zh
Priority to AU2008241868A priority patent/AU2008241868A1/en
Publication of WO2008130009A1 publication Critical patent/WO2008130009A1/ja
Anticipated expiration legal-status Critical
Priority to US13/850,453 priority patent/US20130210668A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

　被検者由来のサンプルにおいて、配列番号203～752で示される塩基配列からなる群より選択される、少なくとも１つの塩基配列又はその相補的配列における、各塩基配列の31番目に存在する一塩基多型のアレル及び／又は遺伝子型をin vitroで検出する工程(工程Ａ)、ならびに、前記工程Ａで検出されたアレル及び／又は遺伝子型を、配列番号203～752で示される塩基配列におけるハイリスクアレルを含むアレル及び／又は遺伝子型の少なくとも１つと比較する工程(工程Ｂ)を含む、緑内障リスクの有無の判定方法。本発明の方法により、サンプル上の本発明の一塩基多型のアレル又は遺伝子型を分析することにより、サンプル提供者の緑内障の進行リスクの高低を判定することができ、このリスクに基づきサンプル提供者は緑内障の予防措置を講じ、又は適切な治療を受けることができる。
PCT/JP2008/057533 2007-04-17 2008-04-17 緑内障進行リスクの判定方法 Ceased WO2008130009A1 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MX2009011080A MX2009011080A (es) 2007-04-17 2008-04-17 Metodo para la determinacion del riesgo del avance de glaucoma.
CA002683836A CA2683836A1 (en) 2007-04-17 2008-04-17 Method for determination of progression risk of glaucoma
JP2009510857A JP5624763B2 (ja) 2007-04-17 2008-04-17 緑内障進行リスクの判定方法
BRPI0810425-5A2A BRPI0810425A2 (pt) 2007-04-17 2008-04-17 Método para determinação do risco de progressão de glaucoma
EP08740595A EP2161334A4 (en) 2007-04-17 2008-04-17 METHOD FOR DETERMINING THE RISK OF PROGRESSION OF GLAUCOMA
US12/596,462 US8431345B2 (en) 2007-04-17 2008-04-17 Method for determination of progression risk of glaucoma
CN200880020582A CN101679971A (zh) 2007-04-17 2008-04-17 青光眼恶化风险的判定方法
AU2008241868A AU2008241868A1 (en) 2007-04-17 2008-04-17 Method for determination of progression risk of glaucoma
US13/850,453 US20130210668A1 (en) 2007-04-17 2013-03-26 Method for determination of progression risk of glaucoma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-108688 2007-04-17
JP2007108688 2007-04-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/850,453 Division US20130210668A1 (en) 2007-04-17 2013-03-26 Method for determination of progression risk of glaucoma

Publications (1)

Publication Number Publication Date
WO2008130009A1 true WO2008130009A1 (ja) 2008-10-30

Family

ID=39875536

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2008/057533 Ceased WO2008130009A1 (ja) 2007-04-17 2008-04-17 緑内障進行リスクの判定方法
PCT/JP2008/057527 Ceased WO2008130008A1 (ja) 2007-04-17 2008-04-17 緑内障発症リスクの判定方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057527 Ceased WO2008130008A1 (ja) 2007-04-17 2008-04-17 緑内障発症リスクの判定方法

Country Status (12)

Country Link
US (4) US20100196895A1 (ja)
EP (4) EP2161334A4 (ja)
JP (5) JP5624763B2 (ja)
KR (2) KR20100016525A (ja)
CN (2) CN101679971A (ja)
AU (2) AU2008241867A1 (ja)
BR (2) BRPI0810425A2 (ja)
CA (2) CA2683836A1 (ja)
MX (2) MX2009011079A (ja)
RU (2) RU2009142225A (ja)
SG (2) SG177968A1 (ja)
WO (2) WO2008130009A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010061697A1 (ja) * 2008-11-27 2010-06-03 株式会社メニコン 正常眼圧緑内障疾患感受性遺伝子及びその利用
WO2018003523A1 (ja) * 2016-06-30 2018-01-04 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
WO2018025521A1 (ja) * 2016-08-05 2018-02-08 京都府公立大学法人 落屑症候群又は落屑緑内障の発症リスクの判定方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG158776A1 (en) * 2008-07-25 2010-02-26 Univ Kaohsiung Medical Using genetic polymorphisms of the bicd1 gene as a method for diagnosing and treating myopia
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
EP2891723B1 (en) * 2009-07-03 2017-10-04 University College Cardiff Consultants Limited Diagnosis and treatment of Alzheimer's disease
US9107617B2 (en) 2009-11-16 2015-08-18 Agency For Science, Technology And Research Obtaining data for automatic glaucoma screening, and screening and diagnostic techniques and systems using the data
WO2011152098A1 (ja) * 2010-06-04 2011-12-08 コニカミノルタエムジー株式会社 イムノクロマトグラフ法のための展開液およびそれを用いた測定法
WO2013159085A1 (en) 2012-04-20 2013-10-24 University Of Virginia Patent Foundation Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure
SG11201501348RA (en) 2012-08-24 2015-04-29 Agency Science Tech & Res Methods and systems for automatic location of optic structures in an image of an eye, and for automatic retina cup-to-disc ratio computation
WO2014082067A1 (en) 2012-11-26 2014-05-30 The Johns Hopkins University Methods and compositions for diagnosing and treating gastric cancer
RU2508043C1 (ru) * 2012-12-20 2014-02-27 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ прогнозирования развития открытоугольной глаукомы у пациентов с глазными проявлениями псевдоэксфолиативного синдрома
US20150315645A1 (en) * 2014-05-03 2015-11-05 The Regents Of The University Of California Methods of identifying biomarkers associated with or causative of the progression of disease
RU2580306C1 (ru) * 2015-03-26 2016-04-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития первичной открытоугольной глаукомы у индивидуумов в зависимости от наличия/отсутствия сопутствующих неинфекционных заболеваний глаз
RU2585381C1 (ru) * 2015-03-27 2016-05-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования показателей гидродинамики у больных первичной открытоугольной глаукомой
JP6542037B2 (ja) * 2015-06-04 2019-07-10 シスメックス株式会社 関節リウマチ患者におけるメトトレキサートの有効性の診断を補助する方法
EP3814532B1 (fr) * 2018-06-29 2025-11-19 bioMérieux Procédé pour déterminer in vitro ou ex vivo le statut immunitaire d'un individu
WO2021086595A1 (en) * 2019-10-31 2021-05-06 Google Llc Using machine learning-based trait predictions for genetic association discovery
CN113444788B (zh) * 2021-08-27 2021-11-02 中国医学科学院北京协和医院 青光眼诊断产品及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000306165A (ja) 1999-02-19 2000-11-02 Toshiba Tec Corp 医療費控除用レシート発行装置および記録媒体
WO2005090602A2 (en) * 2004-03-18 2005-09-29 Sucampo Ag Method for diagnosing or predicting susceptibility to optic nueropathy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5686407A (en) * 1995-08-16 1997-11-11 Alcon Laboratories, Inc. Hepatocyte growth factor to treat glaucoma
US5962230A (en) 1997-02-13 1999-10-05 The University Of Connecticut Diagnosis and treatment of glaucoma
JP2002306165A (ja) 2000-05-17 2002-10-22 Tsubota:Kk 正常眼圧緑内障を含む開放隅角緑内障の関連遺伝子
US20060073506A1 (en) * 2004-09-17 2006-04-06 Affymetrix, Inc. Methods for identifying biological samples
CN101641451A (zh) 2006-10-27 2010-02-03 解码遗传学私营有限责任公司 chr8q24.21上的癌症易感性变体
US20100240057A1 (en) * 2007-11-08 2010-09-23 St. Jude Children's Research Hospital Methods and compositions for the diagnosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000306165A (ja) 1999-02-19 2000-11-02 Toshiba Tec Corp 医療費控除用レシート発行装置および記録媒体
WO2005090602A2 (en) * 2004-03-18 2005-09-29 Sucampo Ag Method for diagnosing or predicting susceptibility to optic nueropathy

Non-Patent Citations (27)

* Cited by examiner, † Cited by third party
Title
"AIGS investigators", OPHTHALMOLOGY, vol. 101, 1994, pages 1445 - 1455
"Wakariyasui Igaku Tokeigaku", TOSHIO MORIZANE, pages: 48 - 80
FAN B.J. ET AL.: "Gene mapping for primary open angle glaucoma", CLINICAL BIOCHEMISTRY, vol. 39, no. 3, 2006, pages 249 - 258, XP005341846 *
FAN B.J. ET AL.: "SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients", MOLECULAR VISION, vol. 11, 2005, pages 625 - 631, XP008122023 *
FRED M. AUSUBLE ET AL.: "Current Protocols in Molecular Biology", JOHN WILEY AND SONS, INC, pages: 2.10.1 - 2.10.16
FUNAYAMA T. ET AL.: "SNPS and Interaction Analyses of Noelin 2, Myocilin, and Optineurin Genes in Japanese Patients with Open-Angle Glaucoma", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 47, no. 12, 2006, pages 5368 - 5375, XP008122025 *
HIGASHIDE T.: "Gankai no Tameno Sentan Iryo Dai 6 Kai SNP to Ryokunaisho", JOURNAL OF THE EYE, vol. 18, no. 6, 2001, pages 745 - 746, XP008116968 *
INAGAKI Y. ET AL.: "Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma", MOLECULAR VISION, vol. 12, 2006, pages 673 - 680, XP008122026 *
ISHIKAWA K. ET AL.: "Association between glaucoma and gene polymorphism of endothelin type A receptor", MOLECULAR VISION, vol. 12, 2006, pages 431 - 437, XP008122556 *
JOSEPH SAMBROOK ET AL.: "Molexular Cloning - A Laboratory Manual", 2001, COLD SPRING HARBOR LABORATORY PRESS
KIM S.H. ET AL.: "Investigations on the association between normal tension glaucoma and single nucleotide polymorphisms of the endothelin-1 and endothelin receptor genes", MOLECULAR VISION, vol. 12, 2006, pages 1016 - 1021, XP008122022 *
KLEIN ET AL., SCIENCE, vol. 308, 2005, pages 385
KOREIKA NI TOMONAU SHITSUMEI SHIKKAN KANREN IDENSHI TAGATA TO ORDER MADE IRYO ENO KATSUYO NI KANSURU KENKYU HEISEI 14 TO 16 NENDO SOGO KENKYU HOKOKUSHO, 2005, XP008142136 *
MAJIMA Y.: "Ganka Kensa Shindanho Kobetsuka Iryo no Jidai ni Mukete no Idenshi Shindan", NIPPON GANKAGAKU ZASSHI, vol. 18, no. 12, 2004, pages 863 - 886 *
MAJIMA Y.: "Koreika ni Tomonau Shitsumei Shikkan Kanren Idenshi Tagat no Order Made Iryo en o Katsuyo", KOREIKA NI TOMONAU SHITSUMEI SHIKKAN KANREN IDENSHI TAGATA TO ORDER MADE IRYO ENO KATSUYO NI KANSURU KENKYU HEISEI 14 TO 16 NENDO SOGO KENKYU HOKOKUSHO, 2005, pages 10 - 14, XP008142121 *
MAJIMA Y.: "Koreika ni Tomonau Shitsumei Shikkan Kanren Idenshi Tagata to Order Made Iryo eno Katsuyo", KOREIKA NI TOMONAU SHITSUMEI SHIKKAN KANREN IDENSHI TAGAT TO ORDER MADE IRYO ENO KATSUYO NI KANSURU KENKYU HEISEI 14 TO 16 NENDO SOGO KENKYU HOKOKUSHO, 2005, pages 15 - 19, XP008142133 *
MANTEL N ET AL., JOURNAL OFTHE NATIONAL CANCER INSTITUTE, vol. 22, 1959, pages 719 - 748
OKADA Y.: "Seijo Gan'atsu Ryokunaisho to Idenshi Tagata: OPA1 deno Kento", JOURNAL OF THE JAPAN OPHTHALMOLOGISTS ASSOCIATION, vol. 73, no. 8, 2002, pages 867 - 870, XP008122099 *
RAY K. ET AL.: "Recent advances in molecular genetics of glaucoma", MOLECULAR AND CELLULAR BIOCHEMISTRY, vol. 253, 2003, pages 223 - 231, XP008122028 *
SCHYMICK J C ET AL., LANCET NEUROLOGY., vol. 6, 2007, pages 322 - 8
SCIENCE, vol. 295, no. 5557, 2002, pages 1077 - 1079
SKOL A.D. ET AL., NATURE GENETICS., vol. 38, 2006, pages 209 - 213
STEEN K ET AL., NATURE GENETICS., vol. 37, 2005, pages 683 - 691
TSAI F.-J. ET AL.: "A codon 31ser-arg polymorphism of the WAF-1/CIP-1/p21/tumor suppressor gene in Chinese primary open-angle glaucoma", ACTA OPHTHALMOLOGICA SCANDINAVICA, vol. 82, 2004, pages 76 - 80, XP008122024 *
WAKARIYASUI IGAKU TOKEIGAKU, EASY MEDICAL STATISTICS, vol. 1, pages 148 - 179
WANG I.J. ET AL.: "The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients", MOLECULAR VISION, vol. 12, 2006, pages 1223 - 1232, XP008122027 *
ZENKEL M. ET AL.: "Differential Gene Expression in Psedoexfoliation Syndrome", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 46, no. 10, 2005, pages 3742 - 3752, XP002471114 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010061697A1 (ja) * 2008-11-27 2010-06-03 株式会社メニコン 正常眼圧緑内障疾患感受性遺伝子及びその利用
WO2018003523A1 (ja) * 2016-06-30 2018-01-04 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
JPWO2018003523A1 (ja) * 2016-06-30 2019-04-18 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
JP7072803B2 (ja) 2016-06-30 2022-05-23 京都府公立大学法人 広義原発開放隅角緑内障の発症リスクの判定方法
WO2018025521A1 (ja) * 2016-08-05 2018-02-08 京都府公立大学法人 落屑症候群又は落屑緑内障の発症リスクの判定方法
JPWO2018025521A1 (ja) * 2016-08-05 2019-05-30 京都府公立大学法人 落屑症候群又は落屑緑内障の発症リスクの判定方法
JP7064215B2 (ja) 2016-08-05 2022-05-10 京都府公立大学法人 落屑症候群又は落屑緑内障の発症リスクの判定方法

Also Published As

Publication number Publication date
AU2008241867A1 (en) 2008-10-30
CN101679971A (zh) 2010-03-24
EP2548961A1 (en) 2013-01-23
CA2683691A1 (en) 2008-10-30
MX2009011080A (es) 2010-03-10
RU2009142225A (ru) 2011-05-27
US20100196895A1 (en) 2010-08-05
RU2009142223A (ru) 2011-05-27
EP2147975A1 (en) 2010-01-27
US8431345B2 (en) 2013-04-30
KR20100016568A (ko) 2010-02-12
JP5624763B2 (ja) 2014-11-12
EP2147975A4 (en) 2010-11-10
US20130210668A1 (en) 2013-08-15
JP5759500B2 (ja) 2015-08-05
JPWO2008130009A1 (ja) 2010-07-22
MX2009011079A (es) 2010-03-10
EP2161334A4 (en) 2010-11-10
EP2565270A1 (en) 2013-03-06
CA2683836A1 (en) 2008-10-30
JP6203217B2 (ja) 2017-09-27
BRPI0810425A2 (pt) 2014-10-07
AU2008241868A1 (en) 2008-10-30
JP2013150628A (ja) 2013-08-08
JP2015180219A (ja) 2015-10-15
EP2161334A1 (en) 2010-03-10
JPWO2008130008A1 (ja) 2010-07-22
KR20100016525A (ko) 2010-02-12
JP2017201995A (ja) 2017-11-16
BRPI0810071A2 (pt) 2014-10-14
SG177968A1 (en) 2012-02-28
US20130012408A1 (en) 2013-01-10
WO2008130008A1 (ja) 2008-10-30
US20110207122A1 (en) 2011-08-25
SG177960A1 (en) 2012-02-28
CN101679970A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
WO2008130009A1 (ja) 緑内障進行リスクの判定方法
WO2007093819A3 (en) Dna conformation (loop structures) in normal and abnormal gene expression
WO2013181125A3 (en) Methods of detecting single nucleotide polymorphisms at codon 600 of human braf
NZ589863A (en) Genetic markers for weight management and methods of use thereof
WO2010096202A3 (en) Sequence-specific detection of nucleotide sequences
WO2009047756A3 (en) Methods and kits for diagnosing lung cancer
WO2013009084A3 (ko) 평행결합 구조의 이중 혼성화 pna 프로브 시스템을 포함하는 실시간 다중 중합효소 연쇄반응에 의한 결핵균 및 비결핵 항산균의 동시 검출용 조성물 및 이를 이용한 검출 방법
WO2008137121A3 (en) Methods for detecting an increased risk for coronary heart disease
NZ701432A (en) Improved method and kit for determining severity and progression of periodontal disease
WO2009153667A3 (en) Method for the detection of ovarian cancer
WO2011003690A8 (en) Highly sensitive rapid isothermal method for the detection of point mutations and snps, a set of primers and a kit therefor
WO2009057294A1 (ja) 肝臓癌関連遺伝子、及び肝臓癌リスクの判定方法
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
EP1988178A3 (en) Nucleotide primer set and nucleotide probe for detecting genotype of serum amyloid A1(SAA1)
WO2016133380A8 (en) Methods and snp detection kits for predicting palm oil yield of a test oil palm plant
WO2007066831A3 (en) Method of detecting human papilloma virus by using nucleic acid amplification method and nucleic acid chain-immobilized carrier
UA118676C2 (uk) СПОСІБ ВИЯВЛЕННЯ РОСЛИНИ Zea mays, ЯКА МІСТИТЬ ЩОНАЙМЕНШЕ ОДИН АЛЕЛЬ, АСОЦІЙОВАНИЙ З ОПТИМІЗАЦІЄЮ ВОДОСПОЖИВАННЯ
WO2006088911A3 (en) Sequence-specific detection of nucleotide sequences
WO2009000764A9 (de) Verfahren und schnelltest zum nachweis spezifischer nukleinsäuresequenzen
NZ602418A (en) Use of brown midrib-3 gene specific markers in maize for trait introgression
WO2007128984A3 (en) Breast cancer makers
WO2008049022A3 (en) Methods for detection of cancer
WO2009133473A3 (en) Isothermal detection methods and uses thereof
WO2008102606A1 (ja) ゲノムdna断片の増幅または欠失の検出方法
WO2010037020A3 (en) Compositions and methods for determining the likelihood of twinning

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880020582.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740595

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009510857

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2683836

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/011080

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 12596462

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 581104

Country of ref document: NZ

Ref document number: 2008241868

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 20097023715

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008740595

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009142225

Country of ref document: RU

Ref document number: 6764/CHENP/2009

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2008241868

Country of ref document: AU

Date of ref document: 20080417

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0810425

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20091019